Vaxxas, a clinical-stage biotechnology company, today announced the appointments of three globally respected vaccine experts as advisors to its product development and strategy team as the company ...

Some CHPs face challenges tracking nomadic communities as they move long distances. It’s costly to follow these households, ...

Some CHPs face challenges tracking nomadic communities as they move long distances. It’s costly to follow these households, ...

As Kansas deals with one of the largest tuberculous outbreaks in the nation since the 1950s, Californians may be wondering ...

Bacille Calmette-Guérin (BCG) is the vaccine for tuberculosis, but according to Collins, it is not routinely given in the U.S. According to the CDC, this is due to several reasons, including the mixed ...

A tuberculosis outbreak started over a year ago in the Kansas City area, but it's now drawing national attention.

Tuberculosis is a serious global health threat that infected more than 10 million people in 2022. Spread through the air and ...

Tuberculosis is one of the leading causes of infectious disease-related mortality worldwide, and vaccines have been the primary preventive therapy for many decades. Currently, Mycobacterium bovis ...

A review of the recent literature on novel TB vaccines reveals that DNA vaccination is one of the most commonly published approaches to protect against virulent challenge in animal models.

GlaxoSmithKline has spent 20 years trying to develop an improved vaccine for tuberculosis, and new data for its lead candidate M72/AS01E suggests it is getting closer to a breakthrough in the disease.